Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Amicus Therapeutics (FOLD) Debt Ratio (2016 - 2023)

Amicus Therapeutics filings provide 14 years of Debt Ratio readings, the most recent being 0.02 for Q2 2023.

  • On a quarterly basis, Debt Ratio fell 25.98% to 0.02 in Q2 2023 year-over-year; TTM through Jun 2023 was 0.02, a 25.98% decrease, with the full-year FY2022 number at 0.03, up 41.64% from a year prior.
  • Debt Ratio hit 0.02 in Q2 2023 for Amicus Therapeutics, down from 0.02 in the prior quarter.
  • In the past five years, Debt Ratio ranged from a high of 0.21 in Q2 2020 to a low of 0.01 in Q4 2020.
  • Median Debt Ratio over the past 5 years was 0.03 (2021), compared with a mean of 0.08.
  • Biggest five-year swings in Debt Ratio: skyrocketed 1437.67% in 2019 and later plummeted 94.21% in 2020.
  • Amicus Therapeutics' Debt Ratio stood at 0.17 in 2019, then plummeted by 94.21% to 0.01 in 2020, then skyrocketed by 107.99% to 0.02 in 2021, then soared by 41.64% to 0.03 in 2022, then crashed by 39.77% to 0.02 in 2023.
  • The last three reported values for Debt Ratio were 0.02 (Q2 2023), 0.02 (Q1 2023), and 0.03 (Q4 2022) per Business Quant data.